Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2022

View Archived Issues

Senescent neurons block neurogenesis in mice

SpFN vaccine confers protection in nonhuman primates against SARS-CoV-2

New TRPA1 antagonists discovered at Boehringer Ingelheim

New macrophage migration inhibitory factor inhibitors identified at Immunophage Biomedical

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

New three-prime repair exonuclease 1 inhibitors described by Tempest Therapeutics

Gene silencing using Toc-HDO technology ameliorated symptoms in EAE models

Researchers develop novel murine model of age-related macular degeneration

Targeting HO-1 signaling pathway against dengue hemorrhagic fever

Alpha Tau enters sponsored research agreement with MD Anderson to study Alpha DaRT in breast cancer

4E Therapeutics discloses new MNK1 and/or MNK2 inhibitors

Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens

Alzinova selects humanized lead candidate of monoclonal antibody ALZ-201

M1 muscarinic receptor mutant mice show accelerated prion neurodegeneration

Tevogen to study allogeneic T-cell technology for Epstein-Barr virus and MS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...